Page last updated: 2024-11-05

pirinixic acid and Cancer of Lung

pirinixic acid has been researched along with Cancer of Lung in 3 studies

pirinixic acid: structure

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, L1
Wang, W1
Dai, M1
Li, H1
Chen, C1
Wang, D1
Skrypnyk, N1
Chen, X1
Hu, W1
Su, Y1
Mont, S1
Yang, S1
Gangadhariah, M1
Wei, S1
Falck, JR1
Jat, JL1
Zent, R1
Capdevila, JH1
Pozzi, A1
Avis, I1
Martínez, A1
Tauler, J1
Zudaire, E1
Mayburd, A1
Abu-Ghazaleh, R1
Ondrey, F1
Mulshine, JL1

Other Studies

3 other studies available for pirinixic acid and Cancer of Lung

ArticleYear
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
    BMC cancer, 2019, Dec-02, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Prolif

2019
PPARα activation can help prevent and treat non-small cell lung cancer.
    Cancer research, 2014, Jan-15, Volume: 74, Issue:2

    Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prol

2014
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
    Cancer research, 2005, May-15, Volume: 65, Issue:10

    Topics: Acetophenones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arachidonic Acid; Caspases

2005